Evidence map›Paper›PMID 41332461›Full record

ReviewJugan geon-gang gwa jilbyeong2024

[Analyzing the Coronavirus Disease 2019 Pandemic Response Governance and Policy (January 2020-December 2021)].

Mi Jeong Park

Abstract readEnglish AbstractReview
In one paragraph

Review in Jugan geon-gang gwa jilbyeong, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Mi Jeong Park연세대학교 보건대학원 국제보건학과.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The severe acute respiratory syndrome coronavirus-2 virus caused the the coronavirus disease 2019 (COVID-19) pandemic, which was a first for the twenty-first century and an infectious disease that spotlighted the importance of the Korea Disease Control and Prevention Agency to public health. In response to the COVID-19 pandemic, the Korea Disease Control and Prevention Agency promptly implemented testing, treatment, and social distancing measures. Only a thorough analysis can evaluate the efficacy of the agency's COVID-19 response policies. It would be challenging to characterize the lessons and preventative actions learned from the findings as accurate insights. This paper analyzes the COVID-19 pandemic response strategy and governance from January 2020 to December 2021 by placing actions taken within the conceptual framework of infectious disease management policy. This strategy establishes a valuable policy evaluation framework that can integrate limitations of policy decisions in response to pandemic infectious diseases with imbalancing ripple effects. Infectious disease control countermeasures provoke an unexpected secondary outcome, like reduced economic growth or social isolation. It is very difficult to balance these negative consequences with the effectiveness of preventing infectious diseases. In other words, infectious disease prevention strategies can be specific obligations in specific contexts that are derived from ex post accountability. Therefore, infectious disease response policy assessment requires a step-by-step framework to evaluate potential negative impacts, and it is important to set parameters in advance to resolve competing interests arising in particular contexts.

Indexed as

COVID-19GovernanceInfectious diseases response policyKorea Disease Control and Prevention AgencyPandemics

Identifiers

PMID41332461
PMCPMC12480355

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.